News
Source of News
WHO Prequalification
Dolutegravir (sodium) prequalified by WHO for HIV treatment
WHO prequalifies Dolutegravir for HIV treatment access
WHO has prequalified Dolutegravir (sodium) manufactured by Micro Labs Limited as an active pharmaceutical ingredient, expanding access to this important HIV treatment option that meets WHO quality standards.
Why this matters
If you are living with HIV, this prequalification means more affordable, WHO-approved treatment options may become available through your healthcare provider or HIV treatment programs.